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�bjecti�e�: t�e e��re��ion o� t�e o�teocla�togenic c�tokine� TNF-α, IL-6 an� IL-1β were immuno�i�toc�emi-
call� e�aluate� in �eri��eral (PG�G) an� central (�G�G) giant cell granuloma� o� t�e jaw� in or�er to �etermine 
�i��erence� between t�e�e two le�ion� an� between t�e two �i�tinct tumor cell �o�ulation� (multinucleate� giant 
cell�, �G�� an� �tromal ��in�le-��a�e� cell�)� 
�tu�� �e�ign: Para�fin-embe��e� ti��ue �ection� �rom 40 PG�G an� 40 �G�G were immuno�i�toc�emicall� 
�taine� u�ing antibo�ie� again�t TNF-α, IL-6 an� IL-1β� T�e �ercentage o� �o�iti�el� �taine� cell� an� t�e �taining 
inten�it� were a��e��e� to �ro�i�e a combine� immunoreacti�it� �core �alue� 
Re�ult�: TNF-α, IL-6 an� IL-1β were e��re��e� in all le�ion�� T�e �G�G com�are� to t�e PG�G ��owe� �ig-
nificantl� increa�e� e��re��ion o� TNF-α an� IL-6 an� �ecrea�e� e��re��ion o� IL-1β b� t�e ��in�le-��a�e� cell� 
an� increa�e� e��re��ion o� IL-1β b� t�e �G��� T�e �G�� �emon�trate� in com�ari�on to t�e �tromal ��in�le-
��a�e� cell� �ignificantl� increa�e� e��re��ion o� all t�ree c�tokine� in bot� PG�G an� �G�G� 
�onclu�ion�: T�e �roinflammator� c�tokine� TNF-α, IL-6 an� IL-1β �eem to be in�ol�e� in t�e growt� �roce�� 
o� PG�G an� �G�G o� t�e jaw�� � �o��ible alteration in t�e ��nt�e�i� or/an� acti�it� o� t�e�e c�tokine� b� t�e 
�tromal ��in�le cell� in t�e �G�G� ma� en�ance o�teol��i� t�roug� t�e �timulation o� o�teocla�t �rogenitor cell�, 
gi�en t�e �act t�at t�e intrao��eou� le�ion� cau�e bone re�or�tion�  
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Introduction 
T�e central giant cell granuloma (�G�G) o� t�e jaw� 
re�re�ent� a non-neo�la�tic an� localize� benign but 
�ometime� aggre��i�e o�teol�tic �roli�eration (1)� Τ�i� 
entit� mo�t commonl� occur� in t�e man�ible a� an e�-
�an�ile ra�iolucenc�, ��ow� �ariable clinical be�a�iour 
an� a �ub�et o� le�ion� ma� e��ibit locall� aggre��i�e 
growt� �attern wit� ra�i� tumour enlargement a��oci-
ate� wit� teet� �i��lacement, root re�or�tion or bone 
cortical �er�oration (2-4)� T�e origin o� �G�G i� uncer-
tain� Local trauma, inflammation, intrao��eou� blee�-
ing an� genetic abnormalitie� �a�e been regar�e� a� 
�o��ible cau�e�, but a unique e��lanation �a� not gaine� 
a wi�e acce�tance (5)�
T�e �eri��eral giant cell granuloma (PG�G) i� an e�-
trao��eou� giant cell le�ion� In t�e oral ca�it� t�i� le-
�ion �re�ent� a� a �e��ile or �e�unculate� �ur�le-brown 
e�o���tic ma��, locate� on t�e gingi�al or t�e al�eolar 
muco�a (4)� In �ome ca�e� o� PG�G a �lig�t �u�erfi-
cial (cu��ing) ero�ion o� t�e a�jacent bone can be �een 
ra�iologicall� (6)� T�e e�act aetiolog� o� PG�G� �till 
remain� unclear� �e�elo�mental or/an� inflammator� 
reaction� in t�e �erio�ontal ligament or t�e �erio�teum 
�a�e been �ro�o�e� to be in�ol�e� (4,6)� Local irritation 
�actor� �uc� a� �oor �ental re�toration�, un�table �ental 
�ro�t�e�i�, �ental e�traction�, �laque an� calculu� ac-
cumulation an� �oo� retention �eem to �la� a �ignificant 
role in t�e �e�elo�ment o� a PG�G (7)�
T�e two le�ion� (�G�G an� PG�G) �emon�trate i�en-
tical �i�to�at�ologic �eature� (4)� T�e� are bot� c�ar-
acterize� b� numerou� multinucleate� giant cell� in a 
fibrobla�tic �a�cularize� �troma wit� o�oi� to ��in�le-
��a�e� cell� w�ic� are t�oug�t to com�o�e a �eterog-
enou� �o�ulation o� macro��age an� fibrobla�tic-like 
cell� (8)�
T�e origin o� t�e multinucleate� giant cell� (�G��) �a� 
been a matter o� con�i�erable intere�t� T�e�e cell� are 
con�i�ere� to be �orme� �rom t�e �u�ion o� monoc�te/
macro��age �recur�or� �i��erentiate� into o�teocla�t� 
un�er t�e influence o� c�tokine� (8-10)� T�e mononu-
clear cell com�onent o� t�e G�G� con�i�t� o� a �o�ula-
tion o� macro��age-like cell�, w�ic� a��ear� to inclu�e 
a �ub�et o� o�teocla�t �recur�or�, an� a �roli�erating 
��in�le-��a�e� �tromal cell �o�ulation w�ic� �a� t�e 
ca�acit� to �i��erentiate along fibrobla�t/o�teobla�t 
line�� T�e fibrobla�t/o�teobla�t-like cell� in G�G� o� t�e 
jaw e��re��ing t�e rece�tor acti�ator o� NF-κB ligan� - 
R�NKL, w�ic� i� a �rimar� me�iator o� o�teocla�t �i�-
�erentiation, acti�ation, an� �ur�i�al, are re��on�ible �or 
in�ucing t�e �ormation o� o�teocla�t-like �G�� �rom 
monoc�te�/macro��age� �oun� in t�e�e le�ion� (11,12)�
�an� o�teotro�ic �ormone� an� c�tokine� �a�e �i-
rect or in�irect �timulator� an� antagoni�tic e��ect� on 
t�e �e�elo�ment o� t�e o�teocla�t�� TNF-α i� a multi-
�unctional c�tokine relea�e� b� acti�ate� monoc�te�, 
macro��age� an� T l�m��oc�te� an� contribute� to 
immune re��on�e�, regulating growt�, �i��erentiation, 
an� �urt�er �ro�uction o� ot�er c�tokine�, inflamma-
tor� me�iator� an� enz�me�� TNF-α i� a �otent bone 
re�or�tion in�ucer t�at �timulate� o�teocla�t �i��eren-
tiation an� acti�ation� T�e �roinflammator� c�tokine� 
IL-6 an� IL-1β, �ro�uct� o� �tromal cell� an� mono-
c�te�, �timulate in a��ociation wit� TNF-α o�teocla�t 
�i��erentiation an� acti�ation in a ��nergi�tic �a��ion� 
T�e�e c�tokine� not onl� regulate o�teocla�togene�i� b� 
�tromal cell�, but al�o act �irectl� on o�teocla�t� an� 
t�eir �recur�or� (11,13,14)� 
T�e role o� TNF-α, IL-6 an� IL-1β in t�e �at�ogene�i� 
o� o�teol�tic le�ion� an� �i�ea�e� wit� �at�ologic bone 
re�or�tion �a� been �ro�e� (11)� T�e�e o�teocla�togenic 
c�tokine� �a�e been in�e�tigate� b� u�ing �ariou� met�-
o�� in giant cell tumor� (G�T�) o� long bone� in �e�eral 
�tu�ie� in �i�o an� in �itro (8,15-17)� T�e e��re��ion o� 
TNF-α �a� al�o been �tu�ie� in �atient� wit� giant cell 
le�ion� o� t�e jaw� (18,19)�
In t�e �re�ent �tu��, t�e TNF-α, IL-6 an� IL-1β e��re�-
�ion were immuno�i�toc�emicall� e�aluate� in �eri��-
eral an� central giant cell granuloma� o� t�e jaw�, in 
or�er to �etermine �o��ible �i��erence� between t�e�e 
two entitie� an� between multinucleate� giant cell� an� 
�tromal ��in�le-��a�e� cell��  To our knowle�ge, t�ere 
are no �tu�ie� in t�e Engli�� literature concerning t�e 
in �itu com�arati�e immuno�i�toc�emical e��re��ion o� 
t�i� tria� o� c�tokine� between t�e PG�G an� �G�G 
o� t�e jaw��
Material and methods 
Study group
In t�i� �tu��, file� o� �atient� wit� a �efinite �iagno�i� o� 
PG�G an� �G�G �rom t�e �e�artment o� �ral Pat�ol-
og� an� �e�icine, Facult� o� �enti�tr�, �ni�er�it� o� 
�t�en� were re�i�e�, t�e �iagno�i� in eac� ca�e �a�ing 
been ma�e on t�e ba�i� o� clinical, ra�iologic an� �i�to-
logic fin�ing�� Formalin-fi�e� an� �ara�fin-embe��e� - 
ti��ue �am�le� o� all t�e ca�e� were retrie�e�� �ll ��eci-
men� were obtaine� �rom �urgical e�ci�ion o� t�e le�ion� 
an� �a� been fi�e� in 10% bu��ere� �ormalin� ���e��-
ment o� �emato��lin an� eo�in-�taine� �ection� o� all 
ca�e� toget�er wit� e�aluation o� clinical an� ra�iologic 
�ata too were �one �o a� t�e �iagno�i� o� t�e le�ion� to 
be confirme�� Fort� (n=40) ca�e� o� PG�G�  an� �ort� 
(n=40) ca�e� o� �G�G�  were �electe�� T�e �election 
criteria inclu�e� t�e �re�ence in t�e �atient�’ recor�� 
o�  �etaile� clinical in�ormation (age, gen�er, anatomic 
location, clinical �eature�, �ign� an� ��m�tom� at �re�-
entation) a� well a� ra�iogra��� (intraoral ra�iogra��ie� 
�or t�e ca�e� o� PG�G�, �anoramic ra�iogra��ie� an�/
or �T �can� �or t�e ca�e� o� �G�G�)� In all t�e ca�e� o� 
�G�G�, laborator� te�t� �alue� �or �erum calcium an� 
��o���oru� concentration�, alkaline ��o���ata�e acti�-
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it� an� �arat��roi� �ormone le�el were al�o a�ailable� 
In all �atient� t�e�e �arameter� were wit�in t�e re�er-
ence range�, e�clu�ing t�e occurrence o� ot�er �i�ea�e� 
w�ic� coul� com�romi�e t�e final �iagno�i� o� �G�G�
�o�t �atient� were �emale� (55% o� ca�e� wit� PG�G 
an� 70% o� ca�e� wit� �G�G)� T�e mean age o� �a-
tient� wit� PG�G an� �G�G wa� 49�2 �ear� an� 45 
�ear� re��ecti�el�� Bot� PG�G an� �G�G ��owe� 
a �re�ilection �or t�e anterior region o� t�e man�ible 
(75% o� PG�G an� 67% o� �G�G)� PG�G� mainl� a�-
�eare� a� re� �e�unculate�  le�ion� wit� �moot� �ur-
�ace an� rubber� con�i�tenc� (59%), w�ile in 34% o� t�e 
ca�e� a �u�erficial, cu�-��a�e� ra�iolucenc� wa� �een 
ra�iogra��icall�� T�e mo�t common clinical fin�ing o� 
�G�G� wa� bon� e��an�ion o� t�e jaw (75%), w�ile in 
more aggre��i�e le�ion� cortical �er�oration, toot� �i�-
�lacement an�, rarel�, �ain an� �are�t�e�ia were al�o 
ob�er�e�� In ra�iogra��ic e�amination, a unilocular or 
multilocular ra�iolucenc� wa� ob�er�e��
Immunohistochemistry
T�e immuno�i�toc�emical �taining wa� �er�orme� on 
3-5μm t�ick �ara�fin-embe��e� ti��ue �ection�� �ec-
tion� were �e�ara�finize� in ��lene, ���rate� t�roug� 
gra�e� alco�ol an� wa��e� wit� Tri�-bu��ere� �aline 
(TB�) �or 10 min an� �i�tille� water �or anot�er 10 min� 
En�ogenou� �ero�i�a�e acti�it� wa� blocke� wit� 3% 
�/� H2O2 in water �or 5-min� �ntigen retrie�al wa� �er-
�orme� �or all antibo�ie� b� �lacement o� t�e �ection� 
in citrate bu��er an� �eating in microwa�e o�en �or 15 
min� �ection� were �e�aratel� incubate� o�ernig�t wit� 
t�e �rimar� antibo�ie� �or TNF-α (mou�e, monoclonal, 
H�2010, H�cult Biotec�, �ilution 1:10), IL-6 (goat, �ol-
�clonal, �c1265, �anta �ruz Biotec�, �ilution 1:150) an� 
IL-1β (mou�e, monoclonal, �c52012, �anta �ruz Bio-
tec�, �ilution 1:400) an� t�en incubate� in t�e biotin-
conjugate� �econ�ar� antibo�� �or 10 min� T�e �tan�-
ar� �tre�ta�i�in–biotin–�ero�i�a�e com�le� met�o� 
wa� �er�orme� to bin� t�e �rimar� antibo�� wit� t�e 
u�e o� a L��B ���tem �ni�er�al Kit (�ako) �or 10 min, 
��B �olution wa� u�e� a� c�romogen �or 5 min an� 
all �ection� were counter�taine� wit� �a�er �΄ �aema-
to��lin �or 1 min an� mounte�� Po�iti�e ti��ue control� 
inclu�e� �uman inflame� �kin �or TNF-α, gliobla�toma 
�or IL-6 an� �iloni�al c��t �or IL-1β� For negati�e con-
trol� �li�e� t�e antibo�� wa� omitte�� 
In eac� �ection, �our �ig�-�ower fiel�� were ran�oml� 
�electe�, wit� a 40X magnification, an� t�e �ercentage 
o� �o�iti�el� �taine� cell� (PP) o� t�e �G�� an� �tro-
mal ��in�le-��a�e� cell� wa� a��e��e� in eac� fiel� b� 
two ob�er�er� a�: 0  (<10% �taine� cell�), 1 (≥10%), 2 
(≥25%), 3 (≥50%), an� 4 (≥75%)� �taining inten�it� (�I) 
wa� gra�e� a�: 0=no e��re��ion, 1=weak, 2=mo�erate 
an� 3=�trong� T�e immuno�i�toc�emical e��re��ion �or 
eac� c�tokine wa� e�aluate� b� u�ing t�e �coring met�-
o� ImmunoReacti�it� �core «IR�» (20,21)�  �ccor�ing 
to t�i�, t�e �core o� t�e �ercentage o� �taine� cell� (PP) 
�or eac� fiel� wa� multi�lie� b� t�e �core o� t�e �taining 
inten�it� (�I) to �ro�i�e a combine� immunoreacti�it� 
�core �alue (IR�) (IR�: PP×�I)� T�e mean o� t�e �our 
fiel�� wa� t�e IR� �core �or t�e �am�le�
Statistical analysis
�tati�tical anal��i� wa� �er�orme� b� �P�� 13�0 �tati�ti-
cal �ackage� Becau�e t�e �ata were con�orme� to abnor-
mal �i�tribution�, t�e non-�arametric �ann-W�itne� 
wa� u�e�� T�e �i��erence� were con�i�ere� a� �tati�ti-
call� �ignificant at le�el �=0�05�
Results
�ll tumor� ��owe� �imilar �i�tological �eature� e��ibit-
ing a great number o� �G�� �urroun�e� b� cell �o�ula-
tion� wit� o�al to ��in�le cell mor��olog� in a loo�e fi-
brillar connecti�e ti��ue �troma wit� man� �mall bloo� 
�e��el�� Hemo�i�erin (11 ca�e� in �G�G an� 7 ca�e� 
Cytokine 
Peripheral Giant Cell Granuloma 
(n=40) 
Central Giant Cell 
Granuloma (n=40) 
(number o� �o�iti�e ca�e�) 


































Table 1. Immunoreacti�it� �core (IR�) �alue� �or TNF-α, IL-6 an� IL-1β in multinucleate� giant cell� an� 
�tromal ��in�le-��a�e� cell�� �om�ari�on between t�e �eri��eral an� central giant cell granuloma�� 
*�tati�ticall� �ignificant �i��erence between  �eri��eral an� central giant cell granuloma��
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in PG�G) an� bone �ormation �emon�trating immature 
o�teoi� trabeculae �urroun�e� b� numerou� o�teobla�t� 
(19 an� 12 ca�e� in �G�G an� PG�G re��ecti�el�) 
were o�ten �een� 
TNF-α, IL-6 an� IL-1β were �etecte� in all ca�e� o� 
PG�G� an� �G�G� (Table 1)� T�e �G�� e��re��e� 
TNF-α, IL-6 an� IL-1β in all ca�e� o� PG�G� an� 
�G�G� a� c�to�la�mic immuno�taining (Figure 1 
�,B,�)� T�e giant cell� �emon�trate� in com�ari�on to 
t�e �tromal ��in�le-��a�e� cell� �ignificantl� increa�e� 
e��re��ion o� all t�ree c�tokine� in bot� PG�G an� 
�G�G� � �ariable e��re��ion �or t�e e�amine� c�-
tokine� wa� ob�er�e� �rom t�e �tromal ��in�le-��a�e� 
cell� in �eri��eral an� central le�ion� (Table 1)� ��e-
cificall�, in 95% o� t�e central an� in 82�5% o� t�e �e-
ri��eral G�G�, t�e ��in�le cell� ��owe� e��re��ion �or 
TNF-α (Fig. 1�)� IL-6 wa� e��re��e� b� t�e �tromal 
��in�le-��a�e� cell� in all ca�e� o� t�e �G�G� (Fig. 
1B) an� in 90% o� PG�G�, w�ile IL-1β wa� e��re��e� 
b� t�e�e cell� in 85% o� t�e �eri��eral an� 45% o� t�e 
central le�ion�� 
T�ere wa� no �tati�ticall� �ignificant �i��erence be-
tween PG�G an� �G�G con�i�ering t�e e��re��ion o� 
TNF-α an� IL-6 b� �G��, in contra�t to t�e �tromal 
��in�le-��a�e� cell�, w�ic� in �G�G� ��owe� a �ig-
nificantl� increa�e� e��re��ion o� t�e�e two c�tokine� 
(Table 1)� T�e com�ari�on between �G�G an� PG�G 
con�i�ering t�e e��re��ion o� IL-1β re�eale� t�at t�e 
�G�G ��owe� �ignificantl� increa�e� IL-1β e��re��ion 
b� �G�� an� �ecrea�e� IL-1β e��re��ion b� �tromal 
��in�le-��a�e� cell� (Fig. 1C).
Discussion
T�e o�teocla�togenic c�tokine� TNF-α, IL-6 an� IL-
1β �a�e been in�e�tigate� in giant cell tumor� (G�T�) 
o� long bone�� W�et�er t�e G�G� o� t�e jaw� an� t�e 
G�T� o� long bone� are reall� a �ingle �at�ologic �roc-
e�� i� an unan�were� que�tion� T�e� are bot� c�aracter-
ize� b� t�e �re�ence o� �G�� , alt�oug� G�T� ma� 
e��ibit �ig�er mean number o� giant cell� �er mea�-
urement fiel�,  �ig�er number o� nuclei �er giant cell, 
greater �ractional area an� relati�e �ize in�e� an� �ig�er 
necro�i� (22,23)� �G�G�, �e��ite t�eir reacti�e nature, 
��ow �ig�er �roli�erati�e acti�it� (24)� T�e� are muc� 
le�� �e�tructi�e an� ten� to in�ol�e a �ounger age grou� 
(23)� G�T� ��ow neo�la�tic c�aracteri�tic� (24)� T�e� 
are u�uall� �ain�ul an� �a�t growing (5), c�aracterize� 
b� an un�re�ictable biological be�a�ior, local aggre�-
�i�ene�� an� �ig� recurrence rate� (25)� T�e �i�tinction 
between t�e G�G� an� t�e G�T� ma� be contro�er�ial, 
but t�eir �i�to�at�ological an� immuno�i�toc�emi-
cal �imilaritie� �eem to reflect a �imilar �at�ogene�i�, 
con�i�ere� to re�re�ent a ��ectrum o� t�e �ame �i�ea�e 
�roce�� (22,23)�
To our knowle�ge t�i� i� t�e fir�t �tu�� regar�ing �imul-
taneou�l� �etermination o� t�e�e t�ree �roinflammato-
r� c�tokine� b� bot� �G�� an� �tromal ��in�le-��a�e� 
cell� in PG�G� an� �G�G� o� t�e jaw�� In a �re�iou� 
�tu��, �maral et al� (18) in�e�tigate� t�e e��re��ion o� 
TNF-α in �eri��eral an� central giant cell le�ion� o� t�e 
jaw� an� �oun� �ecrea�e� tran�cri�tion o� TNF-α gene� 
in all t�e ca�e� �tu�ie� com�are� to �ealt�� control �am-
Fig. 1. (�) TNF-α immuno�i�toc�emical e��re��ion in 
PG�G (Χ60)� �trong �taining inten�it� o� �G�� an� mo�-
erate �taining inten�it� in �tromal ��in�le-��a�e� cell�, (B) 
IL-6 immuno�i�toc�emical e��re��ion in �G�G (Χ60)� 
�trong �taining inten�it� o� �G�� an� mo�erate �taining 
inten�it� in �tromal ��in�le-��a�e� cell�, (�) IL-1β im-
muno�i�toc�emical e��re��ion in �G�G (Χ120)� �trong 
�taining inten�it� o� �G�� �or IL-1β an� no immunoreac-
ti�it� in �tromal ��in�le-��a�e� cell��
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�le�� In a��ition, �e �ouza et al� (19) e�aluate� TNF-α 
e��re��ion b� circulating l�m��oc�te� an� monoc�te� 
in �atient� wit� central giant cell le�ion� o� t�e jaw� an� 
�oun� increa�e� e��re��ion o� t�i� c�tokine b� ��4(+) 
T cell� an� �ecrea�e� �requenc� o� TNF-α+ cell� in 
��68+ circulating monoc�te�� T�e aut�or� �ro�o�e t�at 
a� t�e re�ult� o� t�e �tu�� �emon�trate� an increa�e� 
e��re��ion o� IL-10 b� monoc�te� an� �ince IL-10 in-
�ibit� IL-1, IL-6 an� TNF-α �ro�uction b� acti�ate� 
macro��age� (24), t�e �ig�er e��re��ion o� IL-10 coul� 
�o��ibl� e��lain t�e ob�er�e� �ecrea�e� �requenc� o� 
TNF-α+ cell��  �ccor�ing to t�i� �tu��, it i� intere�ting 
t�at alt�oug� central giant cell le�ion� are locali�e� in 
t�e jaw�, t�e� ma� cau�e �ignificant ���temic �unctional 
alteration� in circulating leukoc�te�� W�et�er t�e cen-
tral giant cell le�ion� ma� cau�e �eri��eral leukoc�te 
acti�ation or t�i� acti�ation ma� be cau�e� b� ot�er �ac-
tor� an� �timulate� t�e �ormation o�  central giant cell 
le�ion� remain� to be eluci�ate� (19)�   
T�e re�ult� o� t�e �re�ent �tu�� are in agreement wit� 
t�o�e �oun� in G�T�, w�ic� ��ow �ariable e��re��ion 
o� t�e TNF-α, IL-6 an� IL-1 b� multinucleate� giant 
cell� an� �tromal ��in�le-��a�e� cell� (8, 15-17)� T�e 
TNF-α, IL-6 an� IL-1β e��re��ion in �eri��eral an� 
central G�G� o� t�e jaw in�icate� t�at t�e�e c�tokine� 
are im�licate� in t�e growt� �roce�� o� bot� e�trao�-
�eou� an� intrao��eou� giant cell le�ion� �u��orting t�e 
�re�iou�l� �tate� o�inion t�at �eri��eral an� central 
G�G� ��are �imilar growt� �otential (26,27)� T�e�e o�-
teocla�togenic c�tokine� com�ri�e a tria� o� �actor� t�at 
interact an� ma� �la� a critical role in �G�� �ormation 
regulating t�e bone re�or�tion (28), �ugge�ting a �o�-
�ible ��nergi�tic role in t�e �e�elo�ment o� G�G�� Τ�e 
�G�� e��ibit �unctional an� ��enot��ic c�aracteri�-
tic� o� o�teocla�t� inclu�ing tartrate-re�i�tant aci� ��o�-
��ata�e, amino-�e�ti�a�e, V-�TPa�e, �� II, �at�e�-
�in K, ��P-9 an� ��68,  �itronectin an� calcitonin 
rece�tor� T�e abo�e �imilaritie� between �G�� an� 
o�teocla�t� are in�icati�e �or a common �i�togene�i� 
(12,21,29)� Recentl�, t�e �tu�� o� �maral et al� (18) in 
PG�G� an� �G�G� ��owe� increa�e� tran�cri�tion o� 
t�e nuclear �actor o� acti�ate� T cell� (NF�Tcl), w�ic� 
i� a ma�ter o� tran�cri�tion in terminal �i��erentiation 
o� o�teocla�t�� T�e�e aut�or� �ro�o�e� t�at t�e �e�elo�-
ment o�  giant cell le�ion� o� t�e jaw� i� �o��ibl� me�i-
ate� b� o�ere��re��ion o� NF�T in t�e nucleu� o� t�e 
�GG�� In t�e �re�ent �tu��, t�e �G�� immuno�tain-
ing �or TNF-α, IL-6 an� IL-1β ma� �o��ibl� be relate� 
to o�teocla�t �i��erentiation�
T�e ��in�le-��a�e� cell� in t�e mononuclear cell com-
�onent o� t�e PG�G an� �G�G �a�e been �ro�e� to 
re�re�ent t�e “�roli�erating com�artment” con�i�ere� 
re��on�ible �or t�e biologic acti�it� o� t�e�e tumor�� 
T�e�e me�enc��mal in origin cell� re�embling imma-
ture o�teobla�t� relea�e a wi�e range o� �actor� (rece�-
tor acti�ator o� NF-κB ligan� - R�NKL, interleukine�, 
inter�eron gamma  -  IFN-γ, macro��age-colon� �timu-
lating �actor - ���F, granuloc�te-macro��age colon� 
�timulating �actor - G���F) t�at recruit monoc�te�/
o�teocla�t �recur�or� an� �romote t�eir �i��erentiation 
into �unctional o�teocla�t� (8,21, 26-28)� In t�e �re�ent 
�tu��, t�e com�ari�on between t�e �eri��eral an� cen-
tral G�G� re�eale� t�at in t�e �G�G t�ere wa� a �ta-
ti�ticall� �ignificant increa�e� e��re��ion o� TNF-α an� 
IL-6 b� t�e ��in�le cell�, but not b� t�e �G��� TNF-α 
i� re��on�ible �or �timulating o�teocla�tic bone re�or�-
tion in �itro a� well a� in �i�o (11,14)� IL-6 i� known 
to �timulate me�enc��mal �rogenitor �i��erentiation 
towar� t�e o�teobla�tic lineage an� i� al�o a �otent anti-
a�o�totic agent on o�teobla�tic cell�� T�e main �ource� 
o� IL-6 in bone are o�teobla�tic cell�, �tromal cell� an� 
not o�teocla�tic cell�, but t�e acti�it� o� IL-6 on bone i� 
it� e��ect on o�teocla�togene�i� (11)�
In contra�t to t�e increa�e� e��re��ion o� TNF-α an� 
IL-6 b� t�e ��in�le cell� in our �tu��, t�e �G�G ��owe� 
�ignificantl� increa�e� IL-1β e��re��ion b� t�e �G�� 
an� �ecrea�e� IL-1β e��re��ion b� t�e �tromal ��in�le-
��a�e� cell�� Gamberi et al� (15) b� u�ing immuno�i�-
toc�emi�tr� an� real-time quantitati�e P�R tec�nique� 
�oun� increa�e� e��re��ion o� IL-6 in G�T� a��ociate� 
wit� �ig�er biological aggre��i�ene��, but wit�out an� 
�ignificant �i��erence� between t�e two cell �o�ula-
tion��  Increa�e� e��re��ion o� TNF-α, IL-1 an� IL-6 
mRN� b� �tromal cell� �a� been ob�er�e� in G�T�  b� 
�tkin� et al (16)� �n t�e ot�er �an�, immunoreacti�it� 
�or IL-1β, IL-6 an� TNF-α al�o confirme� b� in �itu ��-
bri�ization wa� mainl� ob�er�e� in giant cell�, w�erea� 
�tromal cell� ��owe� �cattere� �taining in G�T� (17)�
Regezi (26) ��eculate� t�at t�e �ub�et o� �G�G� t�at 
��ow a locall� aggre��i�e be�a�iour ma� �e�elo� �rom 
a reacti�e le�ion t�roug� an e�igenetic e�ent occurring 
in ��in�le-��a�e� me�enc��mal cell� o� bone re�ulting 
in e�ca�e �rom cell c�cle control� an� in e��re��ion o� 
�rotein� ca�able o� monoc�te recruitment an� �i��eren-
tiation into �G��� ��teocla�tic �i��erentiation i� con-
trolle� b� com�le� interaction� between �PG, R�NK 
an� R�NKL� �PG an� R�NKL are ��nt�e�ize� b� 
�tromal cell�/o�teobla�t�, w�ile R�NK i� localize� at 
t�e cell �ur�ace o� mature o�teocla�t� an� o�teocla�tic 
�recur�or�� �PG in�ibit� o�teol��i� an� block� R�N-
KL/R�NK interaction� TNF-α, IL-6 an� IL-1 ma� 
al�o �la� a role in t�e o�teocla�tic �i��erentiation an� 
increa�e �ro�uction o� bot� R�NKL an� �PG� T�e�e 
c�tokine� al�o act �irectl� on o�teocla�t� an� t�eir �re-
cur�or� an� a��itionall� t�e� �a�e an im�ortant e��ect 
in �timulating R�NKL �ro�uction b� o�teobla�tic cell� 
an� in acting ��nergi�ticall� wit� R�NKL (11)�
T�e re�ult� o� t�e �re�ent �tu�� ��owe� t�at t�e �tromal 
��in�le-��a�e� cell� in �G�G� �emon�trate� increa�e� 
TNF-α, IL-6 an� �ecrea�e� IL-1β immuno�i�toc�emi-
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cal e��re��ion com�are� to t�e PG�G�� �lt�oug�, im-
muno�i�toc�emical o�ere��re��ion ma� not nece��aril� 
reflect o�er�ro�uction o� t�e�e o�teocla�togenic mol-
ecule� b� t�e ��in�le cell� in �G�G�, a �o��ible altera-
tion in t�e ��nt�e�i� or/an� acti�it� o� t�e�e regulator� 
c�tokine� wit�in t�e bone microen�ironment ma� en-
�ance o�teol��i� t�roug� t�e �timulation o� o�teocla�t 
�rogenitor cell�, gi�en t�e �act t�at intrao��eou� le�ion� 
cau�e bone re�or�tion� T�e �G�� in PG�G ma� oc-
ca�ionall� ��ow bone re�or�ti�e ca�acit� a�jacent to 
t�e le�ion� T�e cellular com�o�ition in PG�G �a� been 
��owe� to be �imilar wit� t�at in giant cell le�ion� o� 
�i��erent �ite� an� �G�� e��re�� t�e �ame o�teol�tic 
�rotea�e� an� o�teocla�t-acti�ating c�tokine� in�ol�e� 
in bone metaboli�m (30)� In PG�G, t�e TNF-α, IL-6 
an� IL-1β interrelation� ma� control t�e cellular acti�i-
tie� o� t�e �i��erent cell �o�ulation� (multinuclear cell�, 
monoc�te�/macro��age�, ��in�le fibrobla�t�/o�teob-
la�t�) contributing �o��ibl� mainl� in t�e mec�ani�m� o� 
tumor growt�, an� occa�ionall� o� o�teol��i�� Frie�ric� 
et al� (30) anal�ze� t�e e��re��ion o� �rotea�e� rele�ant 
�or o�teol��i� in giant cell le�ion� an� ��owe� t�at �e-
��ite o� t�e �trong cat�e��in K e��re��ion b� t�e �G�� 
in PG�G�, t�ere wa� no ra�iological e�i�ence �or jaw 
o�teol��i� a�jacent to t�e e�amine� le�ion�� �ccor�ing 
to t�e�e aut�or�, t�e ca�acit� o� cat�e��in K to �egra�e 
bone �eem� to be relate� not to t�e �ig� amount� o� t�i� 
�rotein in giant cell�, but to t�e to�ogra��� o� t�e le�ion 
in relation to t�e a�jacent bone, �ince o�teocla�t� more 
�i�tantl� locate� to bone ma� contain an inacti�e �orm 
(�rocat�e��in K) an� not t�e mature, acti�e cat�e��in 
K�  
In conclu�ion, t�e �roinflammator� c�tokine� TNF-α, 
IL-6 an� IL-1β �eem to be in�ol�e� in t�e growt� �roc-
e�� o� �eri��eral an� central G�G� o� t�e jaw�� Fur-
t�er �tu�ie� are nece��ar� to clari�� t�e �unctional role 
o� t�e�e c�tokine� in t�e �e�elo�ment o� PG�G� an� 
�G�G� an� to �etermine w�et�er control o�er t�e�e 
�rotein� ma� �ro�i�e anot�er �trateg� �or �uture me�i-
cal treatment o� t�e�e tumor��
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